A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities
Başak Özgen Saydam(Dokuz Eylül University), Barış Akıncı(Dokuz Eylül University), Mehmet Sercan Ertürk, İlgın Yıldırım Şimşir(Ege University), Canan Altay(Dokuz Eylül University), Tuğba Arkan(Kocaeli Üniversitesi), Mustafa Seçil(Dokuz Eylül University), Tevfik Demir(Dokuz Eylül University), Zeliha Hekimsoy(Manisa Celal Bayar University), Mustafa Kulaksızoğlu(Necmettin Erbakan University), Gülçin Akıncı(Izmir University), Melda Sonmez(Koç University), Ercan Mıhçı(Akdeniz University), Ümit Çavdar(Dokuz Eylül University)
Cited by 12
Related Papers
GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findings
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2011|157
Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey
|The Journal of Clinical Endocrinology & Metabolism|2016|99
Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy
|Metabolism|2017|88
SLC10A7 mutations cause a skeletal dysplasia with amelogenesis imperfecta mediated by GAG biosynthesis defects
|Nature Communications|2018|70